Maxim initiated coverage of Autonomix (AMIX) with a Buy rating and $5 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMIX:
- Autonomix granted new European Patent for catheter-based technology
- Autonomix engages advisors to guide clinical, regulatory path in cancer pain
- Autonomix granted U.S. patent for catheter-based technology
- Autonomix advances toward U.S. clinical trials in 2025
- Autonomix files $200M mixed securities shelf